Channels - Dynamic AFP-Defined Disease State Transitions in Hospitalized Patients with Hepatocellular Carcinoma Using the Multi-State Markov Model: A Retrospective Cohort Study

Similar Items: Dynamic AFP-Defined Disease State Transitions in Hospitalized Patients with Hepatocellular Carcinoma Using the Multi-State Markov Model: A Retrospective Cohort Study

Quick Look
Impact of Microwave Ablation on Growth Kinetics of Residual versus Synchronous Untreated Hepatocellular Carcinoma: A Retrospective Cohort Study
Quick Look
HAIC Combined with Lenvatinib and Pembrolizumab for Unresectable Hepatocellular Carcinoma: A Retrospective Study
Quick Look
Transarterial Chemoembolization in Hepatocellular Carcinoma: Lessons from a 10-Year Real-World Retrospective Study
Quick Look
Angiogenic Prognostic Signature for Stratification in Hepatocellular Carcinoma
Quick Look
Correlation of Insulin and/or Insulin Secretagogues with the Risk of Hepatocellular Carcinoma and All-Cause Mortality Among Patients with Chronic Hepatitis B and Type 2 Diabetes Mellitus: A Retrospective Cohort Study
Quick Look
Prognostic Relevance of Neddylation-Related Genes in Hepatocellular Carcinoma
Quick Look
Novel Unsupervised Machine Learning Model Using Multi-Parametric Radiomics for Prognostic Stratification of Bifocal Hepatocellular Carcinoma
Quick Look
Prognostic Value of the SEA Score in Double-Negative DCP/AFP Unresectable HCC with Triple Therapy
Quick Look
A Reproducible MRI-Based Quantitative Feature for Differentiating Dysplastic Nodules from Hepatocellular Carcinoma: A Multicenter Retrospective Study
Quick Look
Decoding Treatment Response in Hepatocellular Carcinoma: The Era of Radiomics and Radiogenomics
Quick Look
Rare Long-Term Transformation from Solitary Hepatocellular Carcinoma to Synchronous Double Primary Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Case Report and Literature Review
Quick Look
Stage-Dependent Efficacy of TACE Combined with Tyrosine Kinase and Immune Checkpoint Inhibitors as Conversion Therapy for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Quick Look
Etiology-Driven Mouse Models of Hepatocellular Carcinoma: Paving the Way for Precision Oncology
Quick Look
Comparative Performance of Stereotactic Body Radiotherapy and Lenvatinib in Unresectable Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis: A Propensity Score-Matched Cohort Analysis
Quick Look
Hepatocellular Carcinoma Precursor Lesions: From Pathological Basis to Risk Stratification and Precision Intervention
Quick Look
Intratumoral Fibrosis is a Potential Biomarker in Patients with Hepatocellular Carcinoma Undergoing Liver Resection
Quick Look
Emerging Role of Sirtuins-Mediated Ferroptosis in Hepatocellular Carcinoma Progression: Mechanisms and Therapeutic Perspectives
Quick Look
SNHG6 Promotes Lipid Metabolic Reprogramming in Hepatocellular Carcinoma via Upregulation of SCD
Quick Look
Prognostic Significance of Combined α-Fetoprotein and PIVKA-II for Hepatocellular Carcinoma After Hepatectomy
Quick Look
Comparable Long-Term Survival After Curative Hepatectomy for Solitary Large (5–10 cm) versus Giant (≥10 cm) Hepatocellular Carcinoma: A Retrospective Study
Quick Look
Hepatitis C in North Africa: A Comprehensive Review of Epidemiology, Genotypic Diversity, and Hepatocellular Carcinoma
Quick Look
SR-HCC Score: A Novel Nomogram for Predicting Spontaneous Rupture in Hepatocellular Carcinoma Patients
Quick Look
CECT Radiomics and Liver Fibrosis Markers for Predicting Early Recurrence in Older Patients with Hepatocellular Carcinoma
Quick Look
The Prognostic Value of Circulating Stem Cells Expressing PD-L1 in Patients with Hepatocellular Carcinoma